In the third edition of Global Talks, I engaged in an insightful discussion with Mr. Ahmad Omar, Regional Strategic Account Manager at Boehringer Ingelheim Animal Health, based in Dubai. The interaction explored the rapidly evolving dynamics of poultry health management across emerging markets and the increasing shift toward prevention-led, science-driven strategies that support sustainable, efficient, and responsible poultry production. Mr. Omar shared perspectives on Boehringer Ingelheim’s strong global commitment to animal health and welfare, outlining how innovative vaccine solutions, advanced vaccination technologies, and deep veterinary expertise are empowering poultry producers throughout the IMETA region (India, Middle East, Turkey, and Africa) to manage disease risks and enhance overall flock performance. He also highlighted India’s fast-growing poultry sector, pointing to significant opportunities for integrated health solutions, strengthened biosecurity frameworks, and collaborative partnerships to drive long-term, sustainable industry growth.
The Role of Prevention in Animal Health
Mr. Ahmad Omar highlighted that Boehringer Ingelheim firmly believes in “Prevention Works”, reflecting a strategic shift from treatment-focused approaches to preventive healthcare solutions. He explained that proactive vaccination, robust biosecurity, and science-based management practices are essential to ensure safe, sustainable, and efficient poultry production, particularly in fast-growing markets such as IMETA.
He also noted that animal health is closely linked to food security, public health, and economic development, making prevention-led strategies critical for governments, veterinarians, and producers alike. Dr. Omar further emphasized that early disease prevention not only reduces mortality and production losses but also helps improve predictability, consistency, and profitability at the farm level.
IMETA: A Strategic Growth Region
Discussing the IMETA region, Mr. Omar outlined why it is strategically important for Boehringer Ingelheim Animal Health:
Key Portfolio Focus
– Poultry vaccines and vaccination technologies
– Parasiticides and preventive solutions for companion animals
– Ruminant health and productivity solutions
Market Drivers
– Expanding commercial poultry production
– Rising biosecurity and disease challenges
– Growing awareness of pet health and preventive care
Strategic Priorities
– Excellence in launching innovative vaccines
– Strengthening partnerships with distributors, veterinarians, and industry stakeholders
– Leveraging digital tools for disease monitoring and farmer engagement
India: A Key Driver of Regional Growth
Speaking about India, Mr. Ahmad Omar described the country as one of the fastest-growing poultry markets globally. He noted that the sector’s growth is driven by rising protein demand, increased focus on biosecurity, and strong interest in preventive health measures.
Mr. Omar highlighted Boehringer Ingelheim’s leadership in poultry health through vaccines such as Vaxxitek® and Prevexxion®, which help control major diseases like Infectious Bursal Disease (IBD) and Marek’s Disease, thereby enhancing flock performance and improving food safety. He also emphasized the rapid expansion of India’s companion animal segment, with increasing pet ownership driving demand for parasiticides and preventive healthcare solutions, supported by strategic collaborations with local distributors.
Innovation, Partnerships, and Knowledge Sharing
Mr. Omar stressed that collaboration is central to Boehringer Ingelheim’s regional strategy:
– Veterinary and Academic Engagement: Partnering with veterinary associations and academic institutions to promote best practices in poultry and pet care.
– Digital Transformation: Deploying tools for disease tracking, planning, and data-driven decision-making for veterinarians and farmers.
– Training and Education: Conducting technical seminars, workshops, and programs to enhance preventive healthcare knowledge and improve on-farm implementation.
Sustainability and Community Impact
Mr. Omar highlighted Boehringer Ingelheim’s commitment to sustainability and responsible practices:
– Rabies Elimination: Supporting the global “Zero by 30” initiative to eradicate dog-mediated rabies through vaccination campaigns and awareness programs.
Reducing Antibiotic Dependence: Encouraging preventive vaccination and biosecurity measures to minimize antibiotic usage in livestock.
Capacity Building: Training veterinarians and farmers on responsible farming practices and animal welfare.
Community Development: Enhancing access to veterinary care in rural and underserved areas.
Environmental Responsibility: Reducing operational carbon footprint and promoting eco-friendly packaging.
Future Outlook
Concluding the discussion, Mr. Ahmad Omar shared Boehringer Ingelheim’s forward-looking vision for IMETA and India:
– Leadership in next-generation poultry vaccines for Avian Influenza, IBD, and Newcastle Disease
– Expansion into emerging segments such as aquaculture and advanced diagnostics
– Continued investment in digital innovation, sustainability, and prevention-focused programs
He reaffirmed the company’s commitment to supporting India’s poultry sector through science-driven solutions, strategic partnerships, and long-term sustainable growth initiatives.
